Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation [Phase 1]
A Phase 1 clinical trial is evaluating fecal microbiota transplantation to prevent toxicity in renal cell carcinoma patients treated with im…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Renal Tumour Imaging Using MRI [NA]
The document notes a University College London-sponsored MRI-based imaging trial for renal cancer that is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Multicenter Study of RUS NE [NA]
A multicenter clinical trial evaluating RUS NE for renal tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Rhomboid Intercostal and Subserratus Plane Block Versus Quadratus Lumborum Block in Management of Postoperative Pain After Open Nephrectomy [NA]
This clinical trial compares rhomboid intercostal and subserratus plane block versus quadratus lumborum block for postoperative pain control…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors [Phase 1]
Phase 1 trial update evaluating AB248 alone or with pembrolizumab in adults with solid tumors, including non-small cell lung cancer, melanom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
This study is currently recruiting to evaluate a deep learning method that automatically discriminates between early-stage (T1-T2) and stage…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial [Phase 3]
The PROBE trial is a Phase 3 study evaluating immunotherapy-based combination therapy for metastatic renal cell carcinoma with or without su…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
A2 Biotherapeutics is evaluating A2B395, an allogeneic logic-gated CAR T therapy, in Phase 1/2 trials for solid tumors expressing EGFR and l…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial [Phase 1, Phase 2]
Clinical trial update describing the ICON study, evaluating a combination of an inulin gel with ipilimumab and nivolumab for locally advance…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)
This clinical trial update describes a Duke University study evaluating immune-based biomarkers and circulating tumor cells in patients trea…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating Envafolimab in combination with Axitinib as first-line therapy for advanced renal cell carcinoma; the…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
A University of Miami-led clinical trial evaluating the bacterial and fungal microbiome in patients with calcium oxalate urolithiasis and re…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy [NA]
Clinical trial update on applying an off-clamp and sutureless technique in robot-assisted partial nephrectomy for renal cell carcinoma, with…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: NSAID Use After Robotic Partial Nephrectomy [Phase 2]
This is a Phase 2 clinical trial sponsored by the University of Miami evaluating NSAID use after robotic partial nephrectomy for kidney/rena…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Clinical Trial to Assess the Importance of Nephrectomy [Phase 3]
A Phase 3 trial update evaluating the role of nephrectomy in metastatic renal cell carcinoma has been completed.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy [Phase 2]
A Phase 2 clinical trial from Jinling Hospital in China is investigating multimodal radiotherapy for renal cell carcinoma that progressed af…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004). [Phase 2]
Phase 2 clinical trial update of Adjuvant Intismeran Autogene (V940) with pembrolizumab in renal cell carcinoma; the study is currently acti…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Ivonescimab in the Treatment of Multiple Advanced Tumors [Phase 2]
An update indicating Ivonescimab is being studied in a Phase 2 trial for multiple advanced tumors and is currently recruiting. The trial cov…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma [Phase 3]
Phase 3 trial comparing tivozanib plus nivolumab to tivozanib alone in renal cell carcinoma; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus [Phase 2]
Phase 2 clinical trial updating recruitment for neoadjuvant therapy with lenvatinib and pembrolizumab in renal cell carcinoma with inferior …
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update on cabozantinib alone or with atezolizumab for locally advanced or metastatic solid tumors; the study lists mu…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
A clinical trial is evaluating radiomics-based AI models to predict outcomes in renal cell carcinoma patients after surgery. The study is cu…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy [EARLY_Phase 1]
An early-phase study evaluating a novel humanized CD70-targeted CAR-T cell therapy incorporating TLR2 for advanced renal cell carcinoma; rec…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma [NA]
Clinical trial update evaluating the use of the radiolabeled antibody 124I-cG250 for early detection of response to therapy in metastatic re…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…